Chemotherapy of multiple myeloma (Q37732516)

22 August 2017

1 reference

title

Chemotherapy of multiple myeloma (English)

1 reference

22 August 2017

1 reference

Durie BG

1

1 reference

22 August 2017

publication date

1 January 1991

1 reference

Best Practice and Research: Clinical Haematology

22 August 2017

published in

1 reference

22 August 2017

volume

4

1 reference

22 August 2017

issue

1

1 reference

22 August 2017

page(s)

181-195

1 reference

Chemotherapy for resistant and relapsing multiple myeloma

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980290-2

7 January 2021

Autologous bone marrow transplantation therapy for multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980290-2

7 January 2021

High serum levels of lactic dehydrogenase identify a high-grade lymphoma-like myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980290-2

7 January 2021

Prognostic factors and staging in multiple myeloma: a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980290-2

7 January 2021

A randomized trial of maintenance versus no maintenance melphalan and prednisone in responding multiple myeloma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980290-2

7 January 2021

Marrow transplantation for malignant plasma cell disorders: summary of the Seattle experience

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980290-2

7 January 2021

The role of interleukin-1 and tumour necrosis factor-alpha in human multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980290-2

7 January 2021

Chemotherapy of myeloma: Southwest Oncology Group studies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980290-2

7 January 2021

Reversal of drug-resistance in multiple myeloma with verapamil.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980290-2

7 January 2021

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980290-2

7 January 2021

Serum beta 2-microglobulin in the initial staging and subsequent monitoring of monoclonal plasma cell disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980290-2

7 January 2021

Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980290-2

7 January 2021

Monoclonal gammopathies: new approaches to clinical problems in diagnosis and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980290-2

7 January 2021

Erythropoietin treatment of anemia associated with multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980290-2

7 January 2021

Results of the MRC myelomatosis trials for patients entered since 1980

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980290-2

7 January 2021

Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980290-2

7 January 2021

High-dose chemotherapy and autologous bone marrow transplantation for myeloma.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980290-2

7 January 2021

Ras oncogene mutation in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980290-2

7 January 2021

Growth autonomy and tumorigenicity of interleukin 6-dependent B cells transfected with interleukin 6 cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980290-2

7 January 2021

Are the current criteria for response useful in the management of multiple myeloma?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980290-2

7 January 2021

Infusion of vincristine and doxorubicin with oral dexamethasone as first-line therapy for multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980290-2

7 January 2021

High-dose chemoradiotherapy and allogenic bone marrow transplantation in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980290-2

7 January 2021

10.1016/S0950-3536(05)80290-2

Identifiers

DOI

1 reference

22 August 2017

1 reference